Epidiolex

Jazz Pharmaceuticals Reports Q2 2023 Net Income Of $104.4M, What About Total Revenues?
Jazz Pharmaceuticals Reports Q2 2023 Net Income Of $104.4M, What About Total Revenues?
Divided GOP Helps This State Dodge Bullet From The Pot Lobby, Says Anti-Marijuana Group
Divided GOP Helps This State Dodge Bullet From The Pot Lobby, Says Anti-Marijuana Group
UK Mom's Concern As No Doctor Will Prescribe Cannabis For Her Daughter's 300 Daily Seizures
UK Mom's Concern As No Doctor Will Prescribe Cannabis For Her Daughter's 300 Daily Seizures
Divided GOP Helps This State Dodge Bullet From The Pot Lobby, Says Anti-Marijuana Group
Divided GOP Helps This State Dodge Bullet From The Pot Lobby, Says Anti-Marijuana Group
UK Mom's Concern As No Doctor Will Prescribe Cannabis For Her Daughter's 300 Daily Seizures
UK Mom's Concern As No Doctor Will Prescribe Cannabis For Her Daughter's 300 Daily Seizures

Epidiolex Recent News

Police Raids Dying Man's Hospital Room For Marijuana Extracts, Overreact Much?
Police Raids Dying Man's Hospital Room For Marijuana Extracts, Overreact Much?
Cannabis in Kansas is entirely illegal and penalties for possession are steep. A 69-year-old patient at Hays Medical Center who is in the final stages of terminal, inoperable cancer might face arrest for possessing a vaping device and edible THC paste earlier this month. That is if he lives long enough.
Jazz Pharmaceuticals Announces Q3 2022 Financial Results, Raises Total Revenue Guidance
Jazz Pharmaceuticals Announces Q3 2022 Financial Results, Raises Total Revenue Guidance
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced its financial results late Wednesday for the third quarter of 2022 and raised the mid-point of 2022 total revenue guidance.
Cannabis Drugs Market Could Exceed $2013.42B By 2030, Says New Report
Cannabis Drugs Market Could Exceed $2013.42B By 2030, Says New Report
According to new market research published by Growth+Reports, a part of GRG Health, a global healthcare knowledge service company, the cannabis drugs market is expected to grow at a CAGR of 59% from 2021 to reach US$ 2013.42 billion
Japan Is Inching Toward Cannabis Legalization, Companies Like This One Could Benefit
Japan Is Inching Toward Cannabis Legalization, Companies Like This One Could Benefit
A Japanese health ministry panel recommended that marijuana-derived medicines be treated the same as pharmaceuticals, reported Bloomberg. The expert panel, convened on Thursday, recommended a revision of the country's policy on drugs to enable the import, manufacture and use of medicines derived from cannabis.
North Carolina House Says Yes To Bill Allowing FDA-Approved THC Drugs, Will This Kill Full Medical Marijuana Legalization?
North Carolina House Says Yes To Bill Allowing FDA-Approved THC Drugs, Will This Kill Full Medical Marijuana Legalization?
The North Carolina House passed Senate Bill 448, legalizing FDA-approved THC medications in a 92-9 vote, reported The Carolina Journal.
Kansas Patients Now Have Access To Medicinal Cannabis Without A State Law
Kansas Patients Now Have Access To Medicinal Cannabis Without A State Law
On June 2, Governor Laura Kelly (D) signed new legislation that would allow Kansans to obtain prescription drugs derived from cannabis-related products.
FDA Battles Over CBD Hype Yet Again, This Time Warns Businesses Selling Illegal CBD For Food-Producing Animals
FDA Battles Over CBD Hype Yet Again, This Time Warns Businesses Selling Illegal CBD For Food-Producing Animals
The Food and Drug Administration (FDA) sent letters to four CBD companies warning them against selling unauthorized CBD products for use in food-producing animals. Companies being warned are Haniel Concepts (doing business as Free State Oils), Hope Botanicals, Plantacea LLC (doing business as Kahm CBD
Jazz Pharma Getting New State-Of-The-Art Facility For Cannabis-Based Research And Production
Jazz Pharma Getting New State-Of-The-Art Facility For Cannabis-Based Research And Production
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and its subsidiary, GW Pharmaceuticals have begun construction of its new, state-of-the-art manufacturing facility at Kent Science Park (KSP) in Sittingbourne, UK, with an investment of over $100 million.&nb

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2023 Benzinga | All Rights Reserved